Miastenia gravis (MG) adalah penyakit neuromuskular jang... - dofaq.co
Miastenia gravis (MG ) adalah penyakit neuromuskular jang...Miastenia gravis (MG ) adalah penyakit neuromuskular jangka panjang yang membawa kepada pelbagai tahap kelemahan otot rangka.[1] Otot yang paling kerap terkena adalah otot mata, muka, dan menelan. Ini akan mengakibatkan penglihatan berganda, kelopak mata yang terkulai, masalah berbicara, dan masalah berjalan. Permulaan boleh berlaku secara tiba-tiba. Mereka yang terkena selalunya mempunyai timus yang besar atau mengalami timoma.[1]
Myasthenia Gravis Workup: Laboratory Tests, Radiography, CT, and MRI, Electrodiagnostic Studies
Myasthenia Gravis: New Drugs and a Road to Individualized Treatment
Addressing Juvenile Generalized Myasthenia Gravis
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
Despite positive trial, Roche says Enspryng fell short of expectations in myasthenia gravis
Curcumin protects mice with myasthenia gravis by regulating the gut microbiota, short-chain fatty acids, and the Th17 ...
(PDF) De Novo Onset of Myasthenia Gravis after Kidney Transplantation
5 things we now know about myasthenia gravis
Myasthenia Gravis Presenting as Bulbar Palsy | Article
FDA approves Zilbrysq for generalized myasthenia gravis
Top 10 myasthenia gravis stories of 2023
Myasthenia Gravis Treatment Landscape Rapidly Evolving
FDA Approves UCB’s Complement Inhibitor for Generalized Myasthenia Gravis
Episode 6: Managing Myasthenia Gravis in Primary Care: Best Practices
Potential treatment for rare autoimmune disorder adapted from CAR-T therapy
Guidance for Antibiotic Use in Patients With Myasthenia Gravis
Zilucoplan Approved by FDA for Treatment of Generalized Myasthenia Gravis in Adults | Newsroom
EC approves UCB’s Zilbrysq as generalised myasthenia gravis add-on therapy
A Changing Treatment Landscape in Myasthenia Gravis
